MedTrace Logo

Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Irreversible Pulpitis

NCT06904781 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-04-11

No results posted yet for this study

Summary

This randomised controlled trial aims to compare treatment outcomes between pulpotomy and pulpectomy when used to treat vital primary molars diagnosed with symptomatic irreversible pulpitis. Compared to the standard pulpectomy treatment, pulpotomy is a technically simpler procedure, less time consuming, easier for young patients to tolerate, while retaining the proprioceptive sensation of the tooth - all important advantages when treating young children.

Conditions

  • Irreversible Pulpitis

Interventions

PROCEDURE

Pulpotomy

Pulpotomy is a conservative pulp treatment option where only the coronal pulp is removed and a bioactive medicament (MTA) is placed over the remnant radicular pulp after haemostasis is achieved.

PROCEDURE

Pulpectomy

Pulpectomy is treatment procedure in primary teeth where the entire coronal and radicular pulp is extirpated and the root canal system filled with a resorbable material (Vitapex/Metapex)

Sponsors & Collaborators

  • Jordan University of Science and Technology

    collaborator OTHER

  • Primary Health Care Corporation, Qatar

    collaborator OTHER_GOV

  • Cairo University

    collaborator OTHER

  • Christian Dental College

    collaborator UNKNOWN

  • Oral and Dental Teaching Hospital, Libya

    collaborator UNKNOWN

  • Qatar University

    lead OTHER

Principal Investigators

  • Nebu Philip, MDS, PhD · Qatar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2028-06-30
Completion
2028-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06904781 on ClinicalTrials.gov